Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Clinical trial NCT00128635 · COMPLETED

Trial details

NCT number: NCT00128635
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2005-10-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.